These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 36174477)

  • 41. Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study).
    Bae JC; Kwak SH; Kim HJ; Kim SY; Hwang YC; Suh S; Hyun BJ; Cha JE; Won JC; Kim JH
    Diabetes Metab J; 2022 Jan; 46(1):81-92. PubMed ID: 34130378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and Safety of Use of the Fasting Algorithm for Singaporeans With Type 2 Diabetes (FAST) During Ramadan: A Prospective, Multicenter, Randomized Controlled Trial.
    Lum ZK; Khoo ZR; Toh WYS; Kamaldeen SAK; Shakoor A; Tsou KYK; Chew DEK; Dalan R; Kwek SC; Othman N; Lian JX; Bte Sunari RN; Lee JY
    Ann Fam Med; 2020 Mar; 18(2):139-147. PubMed ID: 32152018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes.
    Kohnert KD; Vogt L; Augstein P; Heinke P; Zander E; Peterson K; Freyse EJ; Salzsieder E
    Horm Metab Res; 2009 Feb; 41(2):137-41. PubMed ID: 19214924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of optimum diabetes care on glycemic control of patients with gestational diabetes during Ramadan fasting.
    Hassanein M; Abuelkheir S; Alsayyah F; Twair M; Abdelgadir E; Basheir A; Rashid F; Al Saeed M; Eltayb F; Abdellatif M; Khalifa A; Alawadi F
    Diabetes Res Clin Pract; 2021 Mar; 173():108669. PubMed ID: 33460717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies.
    Morita M; Sada K; Hidaka S; Ogawa M; Shibata H
    J Diabetes Investig; 2024 Aug; 15(8):1075-1083. PubMed ID: 38685597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "Pre-Ramadan" telemedicine: Effect on fasting experience and glycemic control during ramadan in people with type 1 diabetes.
    Alharthi S; Alrajeh A; Alyusuf E; Alguwaihes AM; Jammah A; Al-Sofiani ME
    Diabetes Metab Syndr; 2022 Aug; 16(8):102567. PubMed ID: 35939941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
    Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A
    Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis.
    Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Heinrich NS; Jørgensen MB; Larsson A; Hilsted L; Feldt-Rasmussen B; Hornum M
    Blood Purif; 2022; 51(7):608-616. PubMed ID: 34583354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
    Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
    Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationships among different glycemic variability indices obtained by continuous glucose monitoring.
    Saisho Y; Tanaka C; Tanaka K; Roberts R; Abe T; Tanaka M; Meguro S; Irie J; Kawai T; Itoh H
    Prim Care Diabetes; 2015 Aug; 9(4):290-6. PubMed ID: 25456706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?
    M'guil M; Ragala MA; El Guessabi L; Fellat S; Chraibi A; Chabraoui L; Israili ZH; Lyoussi B
    Clin Exp Hypertens; 2008 Jul; 30(5):339-57. PubMed ID: 18633757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose.
    Su JB; Wang XQ; Chen JF; Wu G; Jin Y
    Chin Med J (Engl); 2011 Jan; 124(1):144-7. PubMed ID: 21362322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
    Blevins T; Lane W; Rodbard D; Sindelar D; Fan L; Ellinor K; Ilag L; Ly T; Johnson J
    Diabetes Technol Ther; 2021 Jan; 23(1):51-58. PubMed ID: 32631081
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
    Puhr S; Calhoun P; Welsh JB; Walker TC
    Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complications.
    Zhang L; Sun XX; Tian QS
    Acta Diabetol; 2024 Jun; 61(6):679-692. PubMed ID: 38467807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of reducing free sugars on 24-hour glucose profiles and glycemic variability in subjects without diabetes.
    Pappe CL; Peters B; Dommisch H; Woelber JP; Pivovarova-Ramich O
    Front Nutr; 2023; 10():1213661. PubMed ID: 37850088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.